Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Link opens in a new tab
Search content at Penn State
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Critical illness as a result of anti-neoplastic therapy
Robert J. Greiner
, Kevin M. Mulieri
, Robert F. Tamburro
, Raymond Barfield
Department of Pediatrics
Division of Hematology and Oncology
Penn State Cancer Institute
Department of Public Health Sciences
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Critical illness as a result of anti-neoplastic therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Critical Illness
100%
Life-threatening
100%
Antineoplastic Drugs
100%
Chemotherapy
66%
Pediatric Intensivist
66%
Children with Cancer
66%
Pediatric Population
33%
Inflammation
33%
Metabolism
33%
Sepsis
33%
Colon
33%
Oncology Patients
33%
Immune System
33%
Tumor Cells
33%
Malignancy
33%
Organ Function
33%
Renal Failure
33%
Leukemia
33%
Disease Outcome
33%
Lung Injury
33%
Myelosuppression
33%
Radiation Therapy
33%
Cecum
33%
Organ Dysfunction
33%
Severe Sepsis
33%
Electrolyte Levels
33%
Antineoplastic Agents
33%
Level of Functioning
33%
Ventricular Arrhythmia
33%
Diagnostic Challenge
33%
Tumor Burden
33%
Timely Manner
33%
Bacteremia
33%
Anticancer Therapy
33%
Supportive Care
33%
Childhood Cancer
33%
Working Knowledge
33%
Radiological Findings
33%
Healthy Tissue
33%
Radiation Pneumonitis
33%
General Paediatrics
33%
Tetany
33%
Medicine and Dentistry
Pediatrics
100%
Intensivist
100%
Critical Illness
100%
Malignant Neoplasm
66%
Sepsis
66%
Diseases
66%
Neoplasm
33%
Transplantation
33%
Diagnosis
33%
Supportive Care
33%
Colon
33%
Intensive Care
33%
Tumor Cell
33%
Cancer
33%
Renal Failure
33%
Leukemia
33%
Cecum
33%
Oncology
33%
Cancer Treatment
33%
Arrhythmia
33%
Bone Marrow Suppression
33%
Radiation Pneumonia
33%
Childhood Cancer
33%
Pediatric Cancer
33%
Tetany
33%
Radiation Therapy
33%
Immune System
33%
Bloodstream Infection
33%